Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-12-056545
Filing Date
2012-08-09
Accepted
2012-08-09 16:07:14
Documents
1
Period of Report
2012-08-07

Document Format Files

Seq Description Document Type Size
1 4 a4.html 4  
1 4 a4.xml 4 3853
  Complete submission text file 0001104659-12-056545.txt   5455
Mailing Address C/O CALLISTO PHARMACEUTICALS, INC. 420 LEXINGTON AVENUE, SUITE 1609 NEW YORK NY 10170
Business Address
Shailubhai Kunwar (Reporting) CIK: 0001307746 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35268 | Film No.: 121020446

Mailing Address 420 LEXINGTON AVENUE SUITE 1609 NEW YORK NY 10170
Business Address 420 LEXINGTON AVENUE SUITE 1609 NEW YORK NY 10170 212-297-0010
SYNERGY PHARMACEUTICALS, INC. (Issuer) CIK: 0001347613 (see all company filings)

EIN.: 330505269 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations